134 related articles for article (PubMed ID: 27506865)
1. MiR-30c-2* negative regulated MTA-1 expression involved in metastasis and drug resistance of HPV-infected non-small cell lung cancer.
Wu YL; Hsu NY; Cheau-Feng Lin F; Lee H; Cheng YW
Surgery; 2016 Dec; 160(6):1591-1598. PubMed ID: 27506865
[TBL] [Abstract][Full Text] [Related]
2. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
3. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of miR-30c promotes the invasion of non-small cell lung cancer by targeting MTA1.
Xia Y; Chen Q; Zhong Z; Xu C; Wu C; Liu B; Chen Y
Cell Physiol Biochem; 2013; 32(2):476-85. PubMed ID: 23988701
[TBL] [Abstract][Full Text] [Related]
5. microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.
Zhou H; Xu X; Xun Q; Yu D; Ling J; Guo F; Yan Y; Shi J; Hu Y
Oncol Rep; 2012 Mar; 27(3):807-12. PubMed ID: 22139444
[TBL] [Abstract][Full Text] [Related]
6. cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer.
Wu HH; Wu JY; Cheng YW; Chen CY; Lee MC; Goan YG; Lee H
Clin Cancer Res; 2010 Nov; 16(21):5200-10. PubMed ID: 20959404
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-30c inhibits metastasis of ovarian cancer by targeting metastasis-associated gene 1.
Wang X; Qiu LW; Peng C; Zhong SP; Ye L; Wang D
J Cancer Res Ther; 2017; 13(4):676-682. PubMed ID: 28901313
[TBL] [Abstract][Full Text] [Related]
8. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588
[TBL] [Abstract][Full Text] [Related]
9. MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1.
Cao JM; Li GZ; Han M; Xu HL; Huang KM
Biomed Pharmacother; 2017 Sep; 93():554-560. PubMed ID: 28686969
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis.
Chen PM; Cheng YW; Wang YC; Wu TC; Chen CY; Lee H
Neoplasia; 2014 Nov; 16(11):961-71. PubMed ID: 25425970
[TBL] [Abstract][Full Text] [Related]
11. MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b.
Li Y; Chao Y; Fang Y; Wang J; Wang M; Zhang H; Ying M; Zhu X; Wang H
J Exp Clin Cancer Res; 2013 May; 32(1):33. PubMed ID: 23718732
[TBL] [Abstract][Full Text] [Related]
12. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
Wu DW; Cheng YW; Wang J; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
[TBL] [Abstract][Full Text] [Related]
14. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
[TBL] [Abstract][Full Text] [Related]
15. Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer.
Kong X; Xu X; Yan Y; Guo F; Li J; Hu Y; Zhou H; Xun Q
PLoS One; 2014; 9(3):e90810. PubMed ID: 24595016
[TBL] [Abstract][Full Text] [Related]
16. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
18. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis.
Cheng YW; Wu TC; Chen CY; Chou MC; Ko JL; Lee H
Clin Cancer Res; 2008 Nov; 14(22):7173-9. PubMed ID: 19010833
[TBL] [Abstract][Full Text] [Related]
19. Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to Paclitaxel through microRNA-30c-mediated MTA1 reduction.
Lu Y; Wang J; Liu L; Yu L; Zhao N; Zhou X; Lu X
Tumour Biol; 2017 Apr; 39(4):1010428317698353. PubMed ID: 28443468
[TBL] [Abstract][Full Text] [Related]
20. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
Wang G; Wang S; Li C
Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]